BJOG Exchange
DOI: 10.1111/1471-0528.12431 www.bjog.org
Guidance on anti-D administration in early pregnancy
Sir, We have read with interest the retrospective review on errors in anti-D immunoglobulin administration1 and would like to highlight the publication of the National Institute for Clinical Health and Excellence (NICE) guidance on miscarriage and ectopic pregnancy published in December 2012 and specifically the change in guidance relating to the administration of anti D to Rhesus D-negative women before 12 weeks of gestation. This guidance has replaced the green-top guideline published by the Royal College of Obstetricians and Gynaecologists in 2011.2 NICE has recommended that anti-D is not required for women
DOI: 10.1111/1471-0528.12431 www.bjog.org
Guidance on anti-D administration in early pregnancy
Sir, We have read with interest the retrospective review on errors in anti-D immunoglobulin administration1 and would like to highlight the publication of the National Institute for Clinical Health and Excellence (NICE) guidance on miscarriage and ectopic pregnancy published in December 2012 and specifically the change in guidance relating to the administration of anti D to Rhesus D-negative women before 12 weeks of gestation. This guidance has replaced the green-top guideline published by the Royal College of Obstetricians and Gynaecologists in 2011.2 NICE has recommended that anti-D is not required for women
